Patents by Inventor Barbara Murray

Barbara Murray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130243779
    Abstract: The present invention relates to a protective peptide of Enterococcus faecalis (E. faecalis) or a functional active variant thereof, optionally further consisting of additional amino acid residue(s); a nucleic acid coding for the same; a pharmaceutical composition comprising said peptide or said nucleic acid; an antibody or functional active fragment thereof specifically binding to the antigen; a hybridoma cell line which produces said antibody; a method for producing said antibody; a pharmaceutical composition comprising said antibody; the use of said peptide or said nucleic acid for the manufacture of a medicament for the immunization or treatment of a subject; the use of said antibody or functional fragment thereof for the manufacture of a medicament for the treatment of an infection; a method of diagnosing an E. faecalis infection; and the use of said peptide for the isolation and/or purification and/or identification of an interaction partner of the peptide.
    Type: Application
    Filed: February 4, 2010
    Publication date: September 19, 2013
    Applicant: Intercell AG
    Inventors: Eszter Nagy, Beatrice Tschanun, Markus Hanner, Manfred Berger, Andreas Meinke, Alexander Von Gabain, Barbara Murray, Kavindra Singh
  • Publication number: 20050180986
    Abstract: A collagen-binding MSCRAMM entitled Ace from enterococcal bacteria is provided which was homologous to the ligand-binding region of Cna, the collagen-binding MSCRAMM from Staphylococcus aureus, and which can be utilized to inhibit adhesion of enterococcal bacteria to extracellular matrix proteins. The N-terminal region of Ace contained a region (residues 174-319), or A domain, contains several 47-residue tandem repeat units between the collagen-binding site and cell wall-associated regions. The Ace protein can be utilized in methods of preventing and/or treating enterococcal infection, and in addition, antibodies raised against Ace, or its A domain, can be used to effectively inhibit the adhesion of enterococcal cells to a collagen substrate.
    Type: Application
    Filed: April 11, 2005
    Publication date: August 18, 2005
    Inventors: Rebecca Rich, Bernd Kriekemeyer, Rick Owens, Magnus Hook, Barbara Murray, Sreedhar Nallapareddy, George Weinstock
  • Patent number: 4557457
    Abstract: An attachment assembly for lockably but releasably securing a picture frame or the like to a wall surface. The assembly includes a plurality of bracket plates each having a keyhole opening for coaction with a respective headed fastener element secured to the wall surface, and a locking plate mounted for pivotal movement on one of the bracket plates between an unlocked position in which a mask opening in the locking plate unmasks the head portion of the keyhole opening, to allow passage of the head of the wall fastener element, and a locked position in which the mask opening unmasks the slot portion of the keyhole opening. The mask opening includes a edge surface that extends obliquely across the entrance to the keyhole opening slot portion in the unlocked position of the locking plate and coacts with the shank portion of the wall fastener to rotate the locking plate to its locked position as the shank portion advances into the slot portion of the keyhole opening.
    Type: Grant
    Filed: February 6, 1984
    Date of Patent: December 10, 1985
    Assignee: Frame-Lok, Inc.
    Inventors: William Cockfield, Nancy Martin, Barbara Murray